# Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma

> **NCT02202564** · PHASE2 · COMPLETED · sponsor: **Huazhong University of Science and Technology** · enrollment: 81 (actual)

## Conditions studied

- Liver Cancer
- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** LT
- **DRUG:** ADV-TK
- **DRUG:** ganciclovir

## Key facts

- **NCT ID:** NCT02202564
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2011-10
- **Final completion:** 2013-08
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2014-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202564, "Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02202564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*